Module 4: MPS and Alpha–mannosidosis: Challenges in Disease Management – Neurology

Date: Wed, Feb 12, 2020 
Time: 1:00 pm - 2:00 pm CET (Central European Time)

Maurizio Scarpa is Director of the Regional Coordinating Center for Rare Diseases Udine, University Hospital Udine, Italy

Broadcasted live from the WORLD Symposium 2020 on Lysosomal Diseases taking place in Orlando

  • Duration: 45 min (30-min webinar and 15-min update and panel discussion).
  • Language: English
  • Audience: Pediatricians, General Practitioners, Neurologists   

The online session is free to attend, and a certificate of attendance will be provided by the Excellence in Pediatrics Institute for those who will attend. As soon as you register for the selected module you will also be registered for all the modules of the course.

Module Learning Objectives

(1) Understand the pathogenesis of CNS involvement in MPS and Alpha-mannosidosis (2) Learn clinical neurological features on MPS and Alpha-mannosidosis (3) Exploring the principle of neurological therapy in MPS and Alpha-mannosidosis

Click Here to Register and attend the online session. It's free

Important Note: The information provided on this session is intended and designed for use by healthcare professionals with an interest in metabolic diseases, MPS and alpha-mannosidosis. All session viewers are required to register for the selected webinar before accessing the content. Content and views shared are solely those of the speaker.

The free-to-attend online course has been designed to help specialists and general paediatricians to reduce delay in the referral and diagnosis of patients with suspected MPS and alpha-mannosidosis, as well as improving the quality of patient’s lives who have already been diagnosed. On-time diagnosis is crucial for access to treatment and clinical trials, disease management and to access the proper care services at the earliest of the disease possible.

The course is an MPS Europe project in partnership with MetabERN and the Excellence in Pediatrics with the support of Biomarin, Chiesi, Orchard Therapeutics, Regenxbio, Sanofi Genzyme, Takeda, and Ultragenyx. All modules of the course are independently organised by EIP in terms of content, topics and speakers appointed. 


get updates